Gene · 4940
Papers2,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19. | iScience | 2023 | 37260746 | PubTator, text mining | PubMed |
| Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. | Immunity | 2023 | 37257450 | PubTator, text mining | PubMed |
| Accelerated replicative senescence of ataxia-telangiectasia skin fibroblasts is retained at physiologic oxygen levels, with unique and common transcriptional patterns. | Aging Cell | 2023 | 37254625 | PubTator, text mining | PubMed |
| A Chemical Proteomics Approach to Discover Regulators of Innate Immune Signaling. | Viruses | 2023 | 37243198 | PubTator, text mining | PubMed |
| A Dominant-Negative Mutant of ANXA7 Impairs Calcium Signaling and Enhances the Proliferation of Prostate Cancer Cells by Downregulating the IP3 Receptor and the PI3K/mTOR Pathway. | Int J Mol Sci | 2023 | 37240163 | PubTator, text mining | PubMed |
| PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication. | Int J Mol Sci | 2023 | 37240132 | PubTator, text mining | PubMed |
| CAGE sequencing reveals CFTR-dependent dysregulation of type I IFN signaling in activated cystic fibrosis macrophages. | Sci Adv | 2023 | 37235648 | PubTator, text mining | PubMed |
| Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells. | Oncoimmunology | 2023 | 37235066 | PubTator, text mining | PubMed |
| RNA alternative splicing impacts the risk for alcohol use disorder. | Mol Psychiatry | 2023 | 37217680 | PubTator, text mining | PubMed |
| Genomic instability in individuals with sex determination defects and germ cell cancer. | Cell Death Discov | 2023 | 37217472 | PubTator, text mining | PubMed |
| The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer. | Heliyon | 2023 | 37215832 | PubTator, text mining | PubMed |
| Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family. | Mol Neurobiol | 2023 | 37209263 | PubTator, text mining | PubMed |
| Inflammatory and interferon gene expression signatures in patients with mitochondrial disease. | J Transl Med | 2023 | 37208779 | PubTator, text mining | PubMed |
| Stress granules: potential therapeutic targets for infectious and inflammatory diseases. | Front Immunol | 2023 | 37205103 | PubTator, text mining | PubMed |
| Effects of Atherogenic Factors on Endothelial Cells: Bioinformatics Analysis of Differentially Expressed Genes and Signaling Pathways. | Biomedicines | 2023 | 37189834 | PubTator, text mining | PubMed |
| Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines. | Sci Rep | 2023 | 37185361 | PubTator, text mining | PubMed |
| BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5. | Blood Adv | 2023 | 37184294 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. | Hepatology | 2023 | 37158243 | PubTator, text mining | PubMed |
| CpG dinucleotide enrichment in the influenza A virus genome as a live attenuated vaccine development strategy. | PLoS Pathog | 2023 | 37146066 | PubTator, text mining | PubMed |
| Identification of key biomarkers associated with immune cells infiltration for myocardial injury in dermatomyositis by integrated bioinformatics analysis. | Arthritis Res Ther | 2023 | 37118825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4940/papers?page=14